Both PCR (Fig. 4a) and Western blot (Fig. 4b) data confirmed an increase in Runx2 mRNA and protein expression with FGF-2 treatment; whereas TWIST1 expression was decreased in all GCT samples (Fig. 4a, b and c). Here, RUNX2 is linked to granular cell tumor.